Merck begins late-stage trial of experimental Covid-19 drug

Reuters

01 September, 2021, 05:00 pm

Last modified: 01 September, 2021, 05:03 pm

FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid/File Photo

Merck & Co Inc and partner Ridgeback Biotherapeutics said on Wednesday they had begun enrolling patients in a late-stage trial of their experimental drug molnupiravir for prevention of Covid-19 infection.

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Coronavirus chronicle

Merck begins late-stage trial of experimental Covid-19 drug

Comments

Top Stories

MOST VIEWED

Features

Blind people need 25,000 corneas. Sandhani gets around 25

The six billion dollar man

Safa Shareef’s bridal make-up: Contemporary with a ‘deshi’ touch

Why a drastic fuel price hike is dangerous

More Videos from TBS

Oil prices fall due to recession fears

Small business owners in a tight spot due to commodity price hike

How Google Maps operates in Bangladesh

Is BPC really in loss?

Most Read

Diesel price hiked by Tk34 per litre, Octane by Tk46

Housing projects sprouting up by Dhaka-Mawa expressway

July remittance hits two-year high

Dollar rate will be left to market after two months: Governor

Bangladesh to resume talks for Ukrainian wheat import

Summit proposes long-term LNG supply to Petrobangla

Related News

Comments

MOST VIEWED

Related News

Most Read